Purdue Pharma files Chapter 11 after “onslaught of lawsuits”

Despite having no funded debt or judgment creditors, OxyContin maker Purdue Pharma has filed for Chapter 11 bankruptcy protection in New York, with Davis Polk & Wardwell and Dechert advising.


Get unlimited access to all Global Restructuring Review content